PLCB1 and myelodysplastic syndrome: PLCβ1 can be involved in AZA-induced myeloid differentiation through the recruitment of the myeloid zinc finger (MZF-1) on the promoter of PLCβ1, as it is specially recruited in MDS patients responding to AZA therapies [90].